ArticleNeuropsychiatric disease and treatment2018

Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings.

Alejandra Maciel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.